News & Perspective

May 15, 2008

May 15, 2008

Researchers: Pandemic readiness demands mix of antivirals

(CIDRAP News) – Certain mutations that make the H5N1 influenza virus resistant to the antiviral drug oseltamivir (Tamiflu) leave it susceptible to zanamivir (Relenza), a finding that suggests nations should not rely on oseltamivir alone in preparing for a flu pandemic, according to a report published by British scientists this week.

May 14, 2008

May 14, 2008

Provider issue vexes drive to boost flu-shot coverage

– ATLANTA (CIDRAP News) – The drive to increase the number of Americans who get vaccinated against influenza may stumble on disagreements within medicine and public health over where vaccination should take place.